lunes, 22 de enero de 2018

Vaccine for Sarcoma Reprograms Immune System - Ivanhoe Broadcast News, Inc.

Vaccine for Sarcoma Reprograms Immune System - Ivanhoe Broadcast News, Inc.


SEATTLE, Wash. (Ivanhoe Newswire) — Synovial sarcoma is a rare, aggressive cancer of the soft tissue that can be quite resistant to treatment. Doctors at Fred Hutchinson Cancer Research Center have created a vaccine that’s shown some impressive results in a phase one trial, with few minor side effects. Now they’re working on making the vaccine even more effective.

ORLANDO, Fla. (Ivanhoe Newswire) — Caffeine consumed too late in the day may disturb your sleep which could ultimately lead to harming your brain. But your morning cup of coffee contains the chemical EHT, which has been shown to help protect against Alzheimer’s disease.

CHICAGO, Ill. (Ivanhoe Newswire) — One in 133 Americans have celiac disease, although experts say many haven’t been diagnosed. People with celiac disease have a reaction to gluten, which is present in anything made with wheat, rye, or barley. Researchers say they have found a potential cause for the condition, which brings them closer to a cure.

CLEVELAND, Ohio. (Ivanhoe Newswire) — More than 30,000 Americans are living with cystic fibrosis, or CF, for short. Years ago most kids with this disease didn’t make it into their teens, but now, more and more are living longer.

PORTLAND, Ore. (Ivanhoe Newswire) — When you picture today’s bionic man, Johnny Matheny from Port Richey, Florida should come to mind. Doctors amputated his arm during cancer treatment a decade ago. After years of using traditional prosthetics, he became a pioneer of sorts, in a targeted muscle reinnervation program. TMR starts with surgery to rewire nerves in the arm, but that is only the beginning.

Quote of the week:

“Start by doing what's necessary; then do what's possible; and suddenly you are doing the impossible.” 

— St. Francis of Assisi

Give the gift of health news!
Click here to sign up your friends and loved ones for the 

First to Know Newsletter!

Website Information:

Content Licensing:

No hay comentarios:

Publicar un comentario